Javier B. Gil

Javier B. Gil supports the procurement mission of the Naval Medical Research Unit South (N44852), a Department of the Navy research facility focused on advancing military medical readiness against tropical and infectious disease threats. In his capacity, he manages acquisitions for critical laboratory, diagnostic, and field-deployable medical supplies essential to expeditionary force protection. His work centers on securing specialized equipment and biological reagents that enable rapid biothreat detection, entomological surveillance, and point-of-care diagnostics in austere environments, directly aligning with NMRUS’s operational priorities in global health security and force readiness. Gil’s contracting patterns reflect a preference for established commercial suppliers in medical and laboratory supply chains, with consistent engagement with merchant wholesalers specializing in pharmaceuticals, medical equipment, and analytical instrumentation. While no specific contractor names are publicly identifiable, his portfolio demonstrates reliance on vendors with expertise in cold-chain logistics, CLIA-compliant diagnostic kits, and field-deployable lab systems. His procurement approach emphasizes reliability, regulatory compliance, and rapid delivery timelines to support time-sensitive research and deployment cycles. His set-aside preferences reveal a strong orientation toward open competition, with 83.3% of awards issued without set-aside designation. However, he actively incorporates 8(a) competed contracts, accounting for 16.7% of his awards, indicating a measured but intentional commitment to small business participation without compromising mission-critical procurement agility. This balance ensures access to innovative capabilities while maintaining operational continuity. Gil’s primary NAICS focus includes medical and dental equipment wholesaling, drug merchant wholesaling, and analytical laboratory instrument manufacturing, reflecting his specialization in procuring diagnostic tools, biosafety supplies, and field-deployable testing platforms. His technical domain expertise lies in infectious disease research infrastructure, with particular emphasis on vector-borne pathogen detection systems and laboratory-grade instrumentation required for tropical disease surveillance and biothreat mitigation.